1	Pten	Pten	B-NP	NN	O	2	NMOD	-1
2	signaling	signaling	I-NP	NN	O	0	ROOT	0
3	in	in	B-PP	IN	O	2	NMOD	-1
4	gliomas	glioma	B-NP	NNS	O	3	PMOD	-1
5	.	.	O	.	O	2	P	-1

1	In	In	B-PP	IN	O	17	VMOD	-1
2	1997	1997	B-NP	CD	O	1	PMOD	-1
3	,	,	O	,	O	17	P	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	PTEN	PTEN	I-NP	NN	B-DNA	6	NMOD	-1
6	gene	gene	I-NP	NN	I-DNA	17	SUB	-1
7	(	(	O	(	O	16	DEP	-1
8	phosphatase	phosphatase	B-NP	NN	B-protein	11	NMOD	-1
9	and	and	O	CC	O	11	NMOD	-1
10	tensin	tensin	B-NP	NN	O	11	NMOD	-1
11	homolog	homolog	I-NP	NN	O	16	DEP	-1
12	deleted	delete	B-VP	VBN	O	11	NMOD	-1
13	on	on	B-PP	IN	O	12	VMOD	-1
14	chromosome	chromosome	B-NP	NN	B-DNA	13	PMOD	-1
15	10	10	I-NP	CD	I-DNA	14	NMOD	-1
16	)	)	O	)	O	6	NMOD	-1
17	was	be	B-VP	VBD	O	0	ROOT	-1
18	identified	identify	I-VP	VBN	O	17	VC	-1
19	as	as	B-PP	IN	O	18	VMOD	-1
20	a	a	B-NP	DT	O	23	NMOD	-1
21	tumor	tumor	I-NP	NN	B-DNA	23	NMOD	-1
22	suppressor	suppressor	I-NP	NN	I-DNA	23	NMOD	18	suppressor
23	gene	gene	I-NP	NN	I-DNA	19	PMOD	-1
24	on	on	B-PP	IN	O	18	VMOD	-1
25	the	the	B-NP	DT	O	27	NMOD	-1
26	long	long	I-NP	JJ	O	27	NMOD	-1
27	arm	arm	I-NP	NN	O	24	PMOD	-1
28	of	of	B-PP	IN	O	27	NMOD	-1
29	chromosome	chromosome	B-NP	NN	B-DNA	28	PMOD	-1
30	10	10	I-NP	CD	I-DNA	29	NMOD	-1
31	.	.	O	.	O	17	P	-1

1	Since	Since	B-PP	IN	O	6	VMOD	-1
2	then	then	B-NP	RB	O	1	PMOD	-1
3	,	,	O	,	O	6	P	-1
4	important	important	B-NP	JJ	O	5	NMOD	0
5	progress	progress	I-NP	NN	O	6	SUB	-1
6	has	have	B-VP	VBZ	O	0	ROOT	-1
7	been	be	I-VP	VBN	O	6	VC	-1
8	made	make	I-VP	VBN	O	7	VC	-1
9	with	with	B-PP	IN	O	8	VMOD	-1
10	respect	respect	B-NP	NN	O	9	PMOD	-1
11	to	to	B-PP	TO	O	10	NMOD	-1
12	the	the	B-NP	DT	O	13	NMOD	-1
13	understanding	understanding	I-NP	NN	O	11	PMOD	-1
14	of	of	B-PP	IN	O	13	NMOD	-1
15	the	the	B-NP	DT	O	16	NMOD	-1
16	role	role	I-NP	NN	O	14	PMOD	16	role
17	of	of	B-PP	IN	O	16	NMOD	-1
18	the	the	B-NP	DT	O	20	NMOD	-1
19	Pten	Pten	I-NP	NN	B-protein	20	NMOD	-1
20	protein	protein	I-NP	NN	I-protein	17	PMOD	-1
21	in	in	B-PP	IN	O	16	NMOD	-1
22	the	the	B-NP	DT	O	24	NMOD	-1
23	normal	normal	I-NP	JJ	O	24	NMOD	-1
24	development	development	I-NP	NN	O	21	PMOD	2	development
25	of	of	B-PP	IN	O	24	NMOD	-1
26	the	the	B-NP	DT	O	27	NMOD	-1
27	brain	brain	I-NP	NN	O	25	PMOD	-1
28	as	as	B-CONJP	RB	O	21	PMOD	-1
29	well	well	I-CONJP	RB	O	28	DEP	-1
30	as	as	I-CONJP	IN	O	28	DEP	-1
31	in	in	B-PP	IN	O	21	PMOD	-1
32	the	the	B-NP	DT	O	34	NMOD	-1
33	molecular	molecular	I-NP	JJ	O	34	NMOD	-1
34	pathogenesis	pathogenesis	I-NP	NN	O	31	PMOD	0
35	of	of	B-PP	IN	O	34	NMOD	-1
36	human	human	B-NP	JJ	O	37	NMOD	-1
37	gliomas	glioma	I-NP	NNS	O	35	PMOD	-1
38	.	.	O	.	O	6	P	-1

1	This	This	B-NP	DT	O	2	NMOD	-1
2	review	review	I-NP	NN	O	3	SUB	-1
3	summarizes	summarize	B-VP	VBZ	O	0	ROOT	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	current	current	I-NP	JJ	O	6	NMOD	-1
6	state	state	I-NP	NN	O	3	OBJ	-1
7	of	of	B-PP	IN	O	6	NMOD	-1
8	the	the	B-NP	DT	O	9	NMOD	-1
9	art	art	I-NP	NN	O	7	PMOD	-1
10	concerning	concern	B-VP	VBG	O	9	NMOD	-1
11	the	the	B-NP	DT	O	12	NMOD	-1
12	involvement	involvement	I-NP	NN	O	10	OBJ	0
13	of	of	B-PP	IN	O	12	NMOD	-1
14	aberrant	aberrant	B-NP	JJ	O	16	NMOD	16	aberrant
15	Pten	Pten	I-NP	NN	O	16	NMOD	-1
16	function	function	I-NP	NN	O	13	PMOD	-1
17	in	in	B-PP	IN	O	12	NMOD	-1
18	the	the	B-NP	DT	O	19	NMOD	-1
19	development	development	I-NP	NN	O	17	PMOD	2	development
20	of	of	B-PP	IN	O	19	NMOD	-1
21	different	different	B-NP	JJ	O	22	AMOD	-1
22	biologic	biologic	I-NP	JJ	O	23	NMOD	-1
23	features	feature	I-NP	NNS	O	48	NMOD	-1
24	of	of	B-PP	IN	O	23	NMOD	-1
25	malignant	malignant	B-NP	JJ	O	26	NMOD	-1
26	gliomas	glioma	I-NP	NNS	O	24	PMOD	-1
27	,	,	O	,	O	26	P	-1
28	such	such	B-PP	JJ	O	29	PMOD	-1
29	as	as	I-PP	IN	O	26	NMOD	-1
30	loss	loss	B-NP	NN	O	37	NMOD	0
31	of	of	B-PP	IN	O	30	NMOD	-1
32	cell-cycle	cell-cycle	B-NP	NN	O	33	NMOD	-1
33	control	control	I-NP	NN	O	31	PMOD	0
34	and	and	O	CC	O	37	NMOD	-1
35	uncontrolled	uncontrolled	B-NP	JJ	O	37	NMOD	16	uncontrolled
36	cell	cell	I-NP	NN	O	37	NMOD	-1
37	proliferation	proliferation	I-NP	NN	O	29	PMOD	1	proliferation
38	,	,	O	,	O	48	P	-1
39	escape	escape	B-NP	NN	O	48	NMOD	18	escape
40	from	from	B-PP	IN	O	39	NMOD	-1
41	apoptosis	apoptosis	B-NP	NN	O	40	PMOD	5	apoptosis
42	,	,	O	,	O	48	P	-1
43	brain	brain	B-NP	NN	O	44	NMOD	-1
44	invasion	invasion	I-NP	NN	O	48	NMOD	14	invasion
45	,	,	O	,	O	48	P	-1
46	and	and	O	CC	O	48	NMOD	-1
47	aberrant	aberrant	B-NP	JJ	O	48	NMOD	16	aberrant
48	neoangiogenesis	neoangiogenesis	I-NP	NN	O	20	PMOD	3	neoangiogenesis
49	.	.	O	.	O	3	P	-1

1	Most	Most	B-NP	JJS	O	8	SUB	-1
2	of	of	B-PP	IN	O	1	NMOD	-1
3	the	the	B-NP	DT	O	5	NMOD	-1
4	tumor-suppressive	tumor-suppressive	I-NP	JJ	O	5	NMOD	-1
5	properties	property	I-NP	NNS	O	2	PMOD	0
6	of	of	B-PP	IN	O	5	NMOD	-1
7	Pten	Pten	B-NP	NN	O	6	PMOD	-1
8	are	be	B-VP	VBP	O	0	ROOT	-1
9	dependent	dependent	B-ADJP	JJ	O	8	PRD	16	dependent
10	on	on	B-PP	IN	O	9	AMOD	-1
11	its	its	B-NP	PRP$	O	13	NMOD	-1
12	lipid	lipid	I-NP	NN	B-protein	13	NMOD	-1
13	phosphatase	phosphatase	I-NP	NN	I-protein	14	NMOD	-1
14	activity	activity	I-NP	NN	O	10	PMOD	0
15	,	,	O	,	O	14	P	-1
16	which	which	B-NP	WDT	O	14	NMOD	-1
17	inhibits	inhibit	B-VP	VBZ	O	16	SBAR	16	inhibits
18	the	the	B-NP	DT	O	25	NMOD	-1
19	phosphatidylinositol-3'-kinase	phosphatidylinositol-3'-kinase	I-NP	NN	B-protein	25	NMOD	-1
20	(	(	O	(	O	22	DEP	-1
21	PI3K	PI3K	B-NP	NN	B-protein	22	DEP	-1
22	)	)	O	)	O	19	NMOD	-1
23	/Akt	/Akt	B-NP	NN	B-protein	25	NMOD	-1
24	signaling	signaling	I-NP	NN	O	25	NMOD	0
25	pathway	pathway	I-NP	NN	O	17	OBJ	0
26	through	through	B-PP	IN	O	17	VMOD	0
27	dephosphorylation	dephosphorylation	B-NP	NN	O	37	NMOD	13	dephosphorylation
28	of	of	B-PP	IN	O	27	NMOD	-1
29	phosphatidylinositol-	phosphatidylinositol-	B-NP	NN	O	28	PMOD	-1
30	(	(	O	(	O	36	DEP	-1
31	3	3	B-NP	CD	O	35	NMOD	-1
32	,	,	I-NP	,	O	35	P	-1
33	4	4	I-NP	CD	O	35	NMOD	-1
34	,	,	I-NP	,	O	35	P	-1
35	5	5	I-NP	CD	O	36	DEP	-1
36	)	)	O	)	O	27	NMOD	-1
37	-triphosphate	-triphosphate	B-NP	NN	O	26	PMOD	-1
38	.	.	O	.	O	8	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	additional	additional	I-NP	JJ	O	3	NMOD	-1
3	function	function	I-NP	NN	O	11	SUB	-1
4	of	of	B-PP	IN	O	3	NMOD	-1
5	Pten	Pten	B-NP	NN	O	4	PMOD	-1
6	as	as	B-PP	IN	O	3	NMOD	-1
7	a	a	B-NP	DT	O	10	NMOD	-1
8	dual-specificity	dual-specificity	I-NP	NN	B-protein	10	NMOD	-1
9	protein	protein	I-NP	NN	I-protein	10	NMOD	-1
10	phosphatase	phosphatase	I-NP	NN	I-protein	6	PMOD	-1
11	may	may	B-VP	MD	O	0	ROOT	-1
12	also	also	I-VP	RB	O	11	VMOD	-1
13	play	play	I-VP	VB	O	11	VC	0
14	a	a	B-NP	DT	O	15	NMOD	-1
15	role	role	I-NP	NN	O	13	OBJ	0
16	in	in	B-PP	IN	O	13	VMOD	-1
17	glioma	glioma	B-NP	NN	O	18	NMOD	-1
18	pathogenesis	pathogenesis	I-NP	NN	O	16	PMOD	0
19	.	.	O	.	O	11	P	-1

1	Besides	Besides	B-PP	IN	O	0	ROOT	-1
2	the	the	B-NP	DT	O	3	NMOD	-1
3	wealth	wealth	I-NP	NN	O	1	PMOD	-1
4	of	of	B-PP	IN	O	3	NMOD	-1
5	data	datum	B-NP	NNS	O	4	PMOD	-1
6	elucidating	elucidate	B-VP	VBG	O	5	NMOD	-1
7	the	the	B-NP	DT	O	9	NMOD	-1
8	functional	functional	I-NP	JJ	O	9	NMOD	-1
9	roles	role	I-NP	NNS	O	6	OBJ	0
10	of	of	B-PP	IN	O	9	NMOD	-1
11	Pten	Pten	B-NP	NNP	O	15	VMOD	-1
12	,	,	O	,	O	15	P	-1
13	recent	recent	B-NP	JJ	O	14	NMOD	-1
14	studies	study	I-NP	NNS	O	15	SUB	-1
15	suggest	suggest	B-VP	VBP	O	10	SBAR	-1
16	a	a	B-NP	DT	O	18	NMOD	-1
17	diagnostic	diagnostic	I-NP	JJ	O	18	NMOD	-1
18	significance	significance	I-NP	NN	O	15	OBJ	-1
19	of	of	B-PP	IN	O	18	NMOD	-1
20	PTEN	PTEN	B-NP	NN	B-DNA	22	NMOD	-1
21	gene	gene	I-NP	NN	I-DNA	22	NMOD	-1
22	alterations	alteration	I-NP	NNS	O	19	PMOD	16	alterations
23	as	as	B-PP	IN	O	15	VMOD	-1
24	a	a	B-NP	DT	O	26	NMOD	-1
25	molecular	molecular	I-NP	JJ	O	26	NMOD	-1
26	marker	marker	I-NP	NN	O	23	PMOD	-1
27	for	for	B-PP	IN	O	26	NMOD	-1
28	poor	poor	B-NP	JJ	O	29	NMOD	-1
29	prognosis	prognosis	I-NP	NN	O	27	PMOD	-1
30	in	in	B-PP	IN	O	26	NMOD	-1
31	anaplastic	anaplastic	B-NP	JJ	O	32	NMOD	-1
32	astrocytomas	astrocytoma	I-NP	NNS	O	35	NMOD	-1
33	and	and	O	CC	O	35	NMOD	-1
34	anaplastic	anaplastic	B-NP	JJ	O	35	NMOD	-1
35	oligodendrogliomas	oligodendroglioma	I-NP	NNS	O	30	PMOD	-1
36	.	.	O	.	O	1	P	-1

1	Furthermore	Furthermore	B-ADVP	RB	O	23	VMOD	-1
2	,	,	O	,	O	23	P	-1
3	the	the	B-NP	DT	O	4	NMOD	-1
4	possibility	possibility	I-NP	NN	O	23	SUB	-1
5	of	of	B-PP	IN	O	4	NMOD	-1
6	selective	selective	B-NP	JJ	O	7	NMOD	-1
7	targeting	targeting	I-NP	NN	O	5	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	-1
9	PTEN	PTEN	B-NP	NN	B-cell_type	12	NMOD	-1
10	mutant	mutant	I-NP	JJ	I-cell_type	12	NMOD	-1
11	tumor	tumor	I-NP	NN	I-cell_type	12	NMOD	-1
12	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	-1
13	by	by	B-PP	IN	O	7	NMOD	-1
14	specific	specific	B-NP	JJ	O	16	NMOD	-1
15	pharmacologic	pharmacologic	I-NP	JJ	O	16	NMOD	-1
16	inhibitors	inhibitor	I-NP	NNS	O	13	PMOD	-1
17	of	of	B-PP	IN	O	16	NMOD	-1
18	members	member	B-NP	NNS	O	17	PMOD	-1
19	of	of	B-PP	IN	O	18	NMOD	-1
20	the	the	B-NP	DT	O	22	NMOD	-1
21	Pten/PI3K/Akt	Pten/PI3K/Akt	I-NP	NN	O	22	NMOD	-1
22	pathway	pathway	I-NP	NN	O	19	PMOD	0
23	opens	open	B-VP	VBZ	O	0	ROOT	-1
24	up	up	B-PRT	RP	O	23	VMOD	-1
25	new	new	B-NP	JJ	O	26	NMOD	-1
26	perspectives	perspective	I-NP	NNS	O	23	OBJ	-1
27	for	for	B-PP	IN	O	26	NMOD	-1
28	a	a	B-NP	DT	O	31	NMOD	-1
29	targeted	target	I-NP	VBN	O	31	NMOD	0
30	molecular	molecular	I-NP	JJ	O	31	NMOD	-1
31	therapy	therapy	I-NP	NN	O	27	PMOD	19	therapy
32	of	of	B-PP	IN	O	31	NMOD	-1
33	malignant	malignant	B-NP	JJ	B-cell_type	34	NMOD	-1
34	gliomas	glioma	I-NP	NNS	I-cell_type	32	PMOD	-1
35	.	.	O	.	O	23	P	-1

